Aspire Medtech is a five-week hybrid program that equips early-stage, technology-based startups with the training, guidance, and investor connections they need to cross the critical funding gap often called the “valley of death.” Through a combination of cohort-based learning, one-on-one mentoring, and hands-on activities, startups enhance their commercialization capability, tackle real-world business challenges, and strengthen their investment readiness. Investor-mentors work directly with teams to simulate due diligence conversations and refine deal room materials in real time, helping startups build the confidence and clarity needed to raise their first round of equity funding.

Applications are currently open for the 2025 Aspire Medtech cohort. Click here to learn more!